Citations 298
S851 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn’s Disease: PROMIS-29 in the SEAVUE Study
Lewis, James D. , Irving, Peter M., Hoops, Timothy, Izanec, James L., Ding, Zhijie , Muser, Erik, Gasink, Christopher , Lewis, James D , Allez, Matthieu , Ma, Tony Xuyen , Panaccione, Remo , Loftus, Edward V. , Danese, Silvio , Sands, Bruce E
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S395-S395
S778 A Cross-Sectional Evaluation of the Prevalence of Pulmonary Diseases in Patients With Inflammatory Bowel Disease
Pemmasani, Gayatri , Tremaine, William J., Loftus, Edward V.
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S360-S361
S773 Rapidity of Symptom Control with Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two Randomized Phase 3 Studies
Takeuchi, Ken , Gao, Xiang , Ilo, Dapo, Finney‐Hayward, Tricia , Phillips, Charles M., Yao, Xuan , Loftus, Edward V. , Panaccione, Remo , Danese, Silvio , Vermeire, Séverine
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S359-S359
S772 Risankizumab Therapy Induces Improvements in Endoscopic Endpoints in Patients With Moderate-To-Severe Crohn’s Disease: Results From the Phase 3 ADVANCE and MOTIVATE Studies
Ferrante, Marc , Baert, Filip , Feagan, Brian G. , Ran, Zhihua , D’Haens, Geert , Song, Alexandra , Neimark, Ezequiel, Liao, Xiaomei, Berg, Sofie, Wallace, Kori, Bossuyt, Peter , Danese, Silvio , Loftus, Edward V. , Panés, Julián , Peyrin‐Biroulet, Laurent , Armuzzi, Alessandro , Zhou, Qian , Panaccione, Remo
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S357-S358
S771 Efficacy and Safety of Upadacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase 3 U-ACCOMPLISH Study
Pangan, Aileen L., Greenbloom, Susan, D’Haens, Geert , Sandborn, William J. , Reinisch, Walter , Sanchez-Gonzalez, Yuri, Xian, Wangang, Liu, Jian-Zhong , Weinreich, Michael , Vermeire, Séverine , Danese, Silvio , Zhou, Wen , Panés, Julián , Juillerat, Pascal , Lindsay, James Oliver , Loftus, Edward V. , Reinisch, Walter , Huang, Bidan , Panaccione, Remo
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S357-S357
S770 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn’s Disease: IBDQ in the SEAVUE Study
Hoops, Timothy, Izanec, James , Ding, Zhijie , Muser, Erik, Gasink, Christopher , Sandborn, William J. , Loftus, Edward V. , Danese, Silvio , Panaccione, Remo , Ma, Tony Xuyen , Irving, Peter Miles , Allez, Matthieu
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S355-S357
S763 A Cohort Study of the Age of Menopause in Female Patients With and Without Inflammatory Bowel Disease
Moktan, Varun , Daoud, Nader , Tremaine, William J., Kane, Sunanda V. , Hochwald, Alexander , Hodge, David O. , Loftus, Edward V. , Faubion, Stephanie S. , Farraye, Francis A.
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S352-S353
S754 Risankizumab as Induction Therapy in Patients with Moderately to Severely Active Crohn’s Disease Who Failed 1 vs >1 Prior Biologic Treatment: Results From the MOTIVATE Study
Dubinsky, Marla C. , Ferrante, Marc , Song, Alexandra , Liao, Xiaomei, Berg, Sofie, Duan, W. Rachel, Wallace, Kori, Feagan, Brian G. , Panaccione, Remo , Schreiber, Stefan , Peyrin‐Biroulet, Laurent , Loftus, Edward V. , Huang, Bidan
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S348-S348
S737 Effect of Risankizumab on Patient-Reported Outcomes in Patients With Crohn’s Disease With Inadequate Response or Intolerance to Conventional And/or Biologic Treatments: Results From Phase 3 MOTIVATE and ADVANCE Trials
Louis, Édouard , Lee, Scott D. , Griffith, Jenny, Wallace, Kori, Berg, Sofie, Peyrin‐Biroulet, Laurent , Louis, Edouard , Ghosh, Subrata , Loftus, Edward V.
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S338-S338
S693 Impact of Prior Biologic Exposure on Patient Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study
Nguyen, Dianne, Pondel, Marc , Silver, Michael, Petersen, AnnKatrin, Wolf, Douglas C. , Sturm, Andreas , D’Haens, Geert , Sands, Bruce E , Petersen, AnnKatrin, Panaccione, Remo , Loftus, Edward V. , Colombel, Jean‐Frédéric
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S313-S314